"Promising Results: MIT's Cancer Vaccine Shines in Clinical Trials"
TL;DR Summary
MIT's Darell Irvine, a professor in the departments of Biological Engineering and Materials Science and Engineering, discusses the promise of therapeutic cancer vaccines, which have historically fallen short of expectations in provoking a robust immune response in clinical settings.
MIT's cancer vaccine shows promise in clinical trials Interesting Engineering
Reading Insights
Total Reads
0
Unique Readers
10
Time Saved
0 min
vs 1 min read
Condensed
71%
136 → 39 words
Want the full story? Read the original article
Read on Interesting Engineering